Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery-Reference-Cited by-同舟云学术

Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

Published:2020-07-14 Issue: Volume:Publish Ahead of Print Page:
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Hagi Takaomi,Makino Tomoki,Yamasaki Makoto,Yamashita Kotaro,Tanaka Koji,Saito Takuro,Takahashi Tsuyoshi,Kurokawa Yukinori,Motoori Masaaki,Kimura Yutaka,Nakajima Kiyokazu,Morii Eiichi,Eguchi Hidetoshi,Doki Yuichiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma;Head & Neck;2024-08-13

2. Assessing the outcomes of posterior thoracic para-aortic lymph node dissection after induction chemotherapy in patients with esophageal squamous cell carcinoma;Diseases of the Esophagus;2024-08-02

3. Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort;Esophagus;2024-05-08

4. ASO Author Reflections: Tumor Response After the First Course of Neoadjuvant Chemotherapy Reflects Prognosis After Surgery in Patients with Esophageal Squamous Cell Carcinoma;Annals of Surgical Oncology;2024-05-03

5. Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid Carcinomas;Annals of Surgical Oncology;2024-05-03